Cargando…

Screening for Charles Bonnet syndrome: Should the definition be reconsidered?

PURPOSE: Charles Bonnet syndrome (CBS) is a condition in which individuals with visual impairment (VI) and with no cognitive deficits experience visual hallucinations, typically with no other sensory hallucinations. Although few isolated case reports of CBS from India have been published, the preval...

Descripción completa

Detalles Bibliográficos
Autores principales: Satgunam, PremNandhini, Sumalini, Rebecca, Chittapu, Gayathri, Pamarthi, Gunasree
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611264/
https://www.ncbi.nlm.nih.gov/pubmed/31238427
http://dx.doi.org/10.4103/ijo.IJO_1533_18
_version_ 1783432660064927744
author Satgunam, PremNandhini
Sumalini, Rebecca
Chittapu, Gayathri
Pamarthi, Gunasree
author_facet Satgunam, PremNandhini
Sumalini, Rebecca
Chittapu, Gayathri
Pamarthi, Gunasree
author_sort Satgunam, PremNandhini
collection PubMed
description PURPOSE: Charles Bonnet syndrome (CBS) is a condition in which individuals with visual impairment (VI) and with no cognitive deficits experience visual hallucinations, typically with no other sensory hallucinations. Although few isolated case reports of CBS from India have been published, the prevalence for CBS in India is largely unknown. The primary aim of this study was to estimate CBS prevalence in patients with vision impairment visiting a tertiary eye care center. METHODS: The study was conducted in two phases. In phase 1, patients with VI, age ≥40 years with presenting visual acuity worse than 20/63 were enrolled. In phase 2, patients with presenting visual acuity worse than 20/63 and/or with binocular visual field loss, age ≥18 years were recruited. A CBS survey was administered only to those who passed a screening test for cognition impairment. RESULTS: A total of 218 patients were screened (phase 1 = 113 and phase 2 = 105). Two-hundred ten patients (mean age ± standard deviation = 49.2 ± 17.3 years, males = 139) were found eligible to complete the CBS survey. Fourteen patients were found to have visual hallucinations. In addition, three other patients had visual hallucinations with associated auditory input to the visual imagery. All patients had complete insight about their hallucinations. CONCLUSION: Depending on the inclusion criteria, we found the prevalence for CBS in patients with VI to vary between 6.7% to 8.1% (if including patients with auditory input). More investigation is needed to assess the associated role of other sensory inputs (e.g. auditory) with the visual imagery experienced in CBS.
format Online
Article
Text
id pubmed-6611264
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-66112642019-07-22 Screening for Charles Bonnet syndrome: Should the definition be reconsidered? Satgunam, PremNandhini Sumalini, Rebecca Chittapu, Gayathri Pamarthi, Gunasree Indian J Ophthalmol Original Article PURPOSE: Charles Bonnet syndrome (CBS) is a condition in which individuals with visual impairment (VI) and with no cognitive deficits experience visual hallucinations, typically with no other sensory hallucinations. Although few isolated case reports of CBS from India have been published, the prevalence for CBS in India is largely unknown. The primary aim of this study was to estimate CBS prevalence in patients with vision impairment visiting a tertiary eye care center. METHODS: The study was conducted in two phases. In phase 1, patients with VI, age ≥40 years with presenting visual acuity worse than 20/63 were enrolled. In phase 2, patients with presenting visual acuity worse than 20/63 and/or with binocular visual field loss, age ≥18 years were recruited. A CBS survey was administered only to those who passed a screening test for cognition impairment. RESULTS: A total of 218 patients were screened (phase 1 = 113 and phase 2 = 105). Two-hundred ten patients (mean age ± standard deviation = 49.2 ± 17.3 years, males = 139) were found eligible to complete the CBS survey. Fourteen patients were found to have visual hallucinations. In addition, three other patients had visual hallucinations with associated auditory input to the visual imagery. All patients had complete insight about their hallucinations. CONCLUSION: Depending on the inclusion criteria, we found the prevalence for CBS in patients with VI to vary between 6.7% to 8.1% (if including patients with auditory input). More investigation is needed to assess the associated role of other sensory inputs (e.g. auditory) with the visual imagery experienced in CBS. Wolters Kluwer - Medknow 2019-07 /pmc/articles/PMC6611264/ /pubmed/31238427 http://dx.doi.org/10.4103/ijo.IJO_1533_18 Text en Copyright: © 2019 Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Satgunam, PremNandhini
Sumalini, Rebecca
Chittapu, Gayathri
Pamarthi, Gunasree
Screening for Charles Bonnet syndrome: Should the definition be reconsidered?
title Screening for Charles Bonnet syndrome: Should the definition be reconsidered?
title_full Screening for Charles Bonnet syndrome: Should the definition be reconsidered?
title_fullStr Screening for Charles Bonnet syndrome: Should the definition be reconsidered?
title_full_unstemmed Screening for Charles Bonnet syndrome: Should the definition be reconsidered?
title_short Screening for Charles Bonnet syndrome: Should the definition be reconsidered?
title_sort screening for charles bonnet syndrome: should the definition be reconsidered?
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611264/
https://www.ncbi.nlm.nih.gov/pubmed/31238427
http://dx.doi.org/10.4103/ijo.IJO_1533_18
work_keys_str_mv AT satgunampremnandhini screeningforcharlesbonnetsyndromeshouldthedefinitionbereconsidered
AT sumalinirebecca screeningforcharlesbonnetsyndromeshouldthedefinitionbereconsidered
AT chittapugayathri screeningforcharlesbonnetsyndromeshouldthedefinitionbereconsidered
AT pamarthigunasree screeningforcharlesbonnetsyndromeshouldthedefinitionbereconsidered